• 3 exciting ASX healthcare shares to watch in the 2020s

    Doctor with stethoscope in hand and data graph showing upward trend

    One area of the market that I think is a good place to look for buy and hold options is the small end of the healthcare sector.

    I think here you’ll find a number of companies that have the potential to grow significantly in the future thanks to favourable tailwinds and new technologies.

    Three small cap healthcare shares I am watching closely are listed below. Here’s why I like them:

    Medadvisor Ltd (ASX: MDR)

    The first small cap healthcare share to watch is Medadvisor. It is a growing software systems developer which is addressing gaps in personal medication adherence. The company’s app connects to pharmacy dispensing systems to automatically retrieve medication records and drive an intelligent training, information, and reminder system to ensure correct and reliable medication use. In addition, Medadvisor is also rolling out a medicine delivery service and a telehealth solution.

    Telix Pharmaceuticals Ltd (ASX: TLX)

    Telix Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of diagnostic and therapeutic products based on targeted radiopharmaceuticals or molecularly-targeted radiation. It is developing a portfolio of clinical-stage oncology products that address significant unmet medical need in renal, prostate, and brain cancer. I believe the company has a lot of potential and could prove to be a great long term investment.

    Volpara Health Technologies Ltd (ASX: VHT)

    Volpara is healthcare technology company. It provides software that uses artificial intelligence imaging algorithms to assist with the early detection of breast cancer. It has been a very strong performer in recent years due to the growing popularity of its software with radiologists. And thanks to the quality of the software, recent acquisitions, and its growing North American footprint, I expect the company to deliver further strong growth in FY 2021 and for many years to come.

    And don’t miss this fourth share which has been tipped as a must buy this month.

    One “All In” ASX Buy Alert, that could be one of our greatest discoveries

    Investing expert Scott Phillips has just named what he believes is the #1 Top “Buy Alert” after stumbling upon a little-owned opportunity he believes could be one of the greatest discoveries of his 25 years as a professional investor.

    This under-the-radar ASX recommendation is virtually unknown among individual investors, and no wonder.

    What it offers is an utterly unique strategy to position yourself to potentially profit alongside some of the world’s biggest and most powerful tech companies.

    Potential returns of 1X, 2X and even 3X are all in play. Best of all, you could hold onto this little-known equity for DECADES to come

    Simply click here to see how you can find out the name of this ‘all in’ buy alert… before the next stock market rally.

    Find out the name of Scott’s ‘All in’ Buy Alert

    Returns as of 6/5/2020

    More reading

    James Mickleboro owns shares of TELIXPHARM DEF SET. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of MedAdvisor. The Motley Fool Australia owns shares of and has recommended VOLPARA FPO NZ. The Motley Fool Australia has recommended MedAdvisor. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 3 exciting ASX healthcare shares to watch in the 2020s appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2WllMTf

  • Musk Reopens Tesla’s Plant, Dares Authorities to Arrest Him

    Musk Reopens Tesla’s Plant, Dares Authorities to Arrest Him(Bloomberg) — Elon Musk restarted production at Tesla Inc.’s only U.S. car plant, flouting county officials who ordered the company to stay closed and openly acknowledging he was risking arrest for himself and his employees.“I will be on the line with everyone else,” the chief executive officer said in a tweet Monday. “If anyone is arrested, I ask that it only be me.”After fending off a potentially costly defamation lawsuit and emerging with mild consequences from a court battle with the Securities and Exchange Commission last year, Musk, 48, seems emboldened to again try his luck with the law. The lead lawyer on Tesla’s lawsuit Saturday against California’s Alameda County over its reopening restrictions helped Musk beat the case brought by a cave diver he called a pedophile in 2018.This time around, Musk is doing battle over measures to contain a virus that he downplayed starting in January. After claiming Covid-19 wasn’t all that viral a disease, then calling panic about it “dumb” in March, he’s also theorized fatality rates are overstated, promoted the antimalarial drugs dubiously embraced by President Donald Trump and wrongly predicted that new cases would be close to zero by the end of April.‘Sad Day’Musk has been furious for weeks about restrictions that county officials placed on Tesla operations as part of their effort to slow the spread of the coronavirus. On Saturday, he threatened to pull the company’s headquarters out of California and move them along with future projects to Nevada or Texas. Tesla has roughly 20,000 employees in the San Francisco Bay area, about half of which are in Fremont.California Governor Gavin Newsom sought to ease tensions earlier Monday, saying that he believed Tesla would be able to begin operations as soon as next week.“It would be a sad day if the Fremont police walked into Tesla and arrested Elon Musk,” said Scott Haggerty, the county supervisor for the district in Alameda where Tesla’s Fremont plant is located. “The tweets that go back and forth are unfortunate, and we need to get to the table, talk our way through this and get people back to work in a safe manner.”The Musk-versus-Calfornia battle has come to represent the tense debate that’s playing out in states and counties across America over how fast businesses should be allowed to reopen. To Musk supporters, he’s a hero fighting back against unnecessary government intervention. To his detractors, he’s a reckless and impulsive leader who’s encouraging dangerous behavior that could set back efforts to quell the pandemic.“I don’t think Musk can just fly in the face of the local health order, which is more restrictive than the state’s,” said Haggerty, who has represented the region for 23 years.Conflicting EmailTesla told production workers before Musk’s tweet that it was getting back to work at the Fremont factory. Valerie Capers Workman, Tesla’s head of North American human resources, emailed production staff to notify them that their furlough ended Sunday and that managers will contact them within 24 hours with their start date and schedule. Those who aren’t comfortable returning to work can stay home on unpaid leave but may no longer be eligible for jobless benefits, she said.The email conflicted with remarks that Newsom made during the governor’s daily press briefing, which took place before Musk’s tweet. When asked about Tesla reopening its Fremont plant regardless of Alameda’s order, Newsom said he was unaware.“My understanding is they have had some very constructive conversations,” Newsom said. “My belief and hope and expectation is as early as next week, they will be able to resume.”Tesla sued the county over the weekend after it told the company it didn’t meet criteria to reopen. Newsom, who allowed manufacturing in parts of the state to restart May 8, said Monday that the county was allowed to enforce stricter rules around reopening. The health officers for Alameda and six other San Francisco Bay area counties and cities decided late last month to extend their restrictions on businesses through the end of May.‘Green Light’After Musk’s tweet, Alameda county health officials issued a statement saying Tesla’s Fremont plant was operating beyond what was allowed and that it hoped the company would “comply without further enforcement measures.” The county has been in an ongoing dialogue over employee health-screening procedures and said it will continue to review Tesla’s plans.Capers Workman told employees that the state had “given the green light for manufacturing to resume.”Musk tweeted over the weekend that Alameda’s refusal to let Tesla reopen the Fremont factory was “the final straw” and that he’d immediately move Tesla’s headquarters to Nevada or Texas.Newsom said Monday the state has a strong relationship with Tesla, calling it “a company that this state has substantively supported for now many, many years.” Musk then thanked the governor in a tweet.For all his bluster, Musk’s fortune has surged along with Tesla’s shares this year. His personal wealth has grown by $12.6 billion in 2020 to more than $40 billion, according to the Bloomberg Billionaires Index.“We have a culture in our state where these huge corporations run by billionaires ‘move fast and break things,’” Lorena Gonzalez, a California assemblywoman, tweeted Monday. “Rules. Orders. Laws. People. All without consequence.”(Updates with Musk’s earlier legal battles in third paragraph)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

    from Yahoo Finance https://ift.tt/3cABwYt

  • Column: Does Elon Musk need California more than California needs Elon Musk?

    Column: Does Elon Musk need California more than California needs Elon Musk?Has Elon Musk worn out his welcome in California at last?

    from Yahoo Finance https://ift.tt/3dCFfVc

  • NVDA | Will NVIDIA Get a Boost From New Gaming Laptops? March was a record quarter for digital spending on games.

  • Most Anticipated Earnings Releases for the trading week beginning May 11th, 2020

  • Mark Cuban’s Secret Shopper Study Finds That 96% of Dallas Businesses Don’t Comply With Reopening Guidelines. This is going to get bad.

  • Strategy Analysis